This week’s Am Law Litigation Daily Litigators of the Week are Latham & Watkins partner Chris Harris and counsel Betsy Marks. The duo helped Mallinckrodt Pharmaceuticals navigate a Chapter 11 confirmation hearing held over 16 days between November and January where the company’s reorganization plan was facing objections from everyone from the U.S. Trustee to the U.S. Securities and Exchange Commission to individual company shareholders.

Despite the objections, U.S. Bankruptcy Judge John Dorsey in Wilmington, Delaware, last week signed off on the company’s reorganization plan, including its deal to settle opioid-related liabilities for roughly $1.7 billion.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]